10^th European Nephrology Conference October 24-26, 2016 Rome, Italy

John Mellas, MD has been practicing nephrology for thirty years in St. Louis, Missouri. Dr Mellas is the senior partner in the largest nephrology practice in St. Louis. He is also chairman of the Nephrology Division at St. Mary’s Health Center where he is actively involved in teaching internal medicine trainees. Dr Mellas has developed a method to measure creatinine clearance in acute kidney injury and has been using it in his practice for the last several years. With this method he is able to detect the onset of renal injury early in its course and with significant accuracy. This method allows one to forecast the course of renal injury prospectively; something that is not possible with the present metrics of renal injury.

Nephrology and Hypertension

Dmitry Zorov has completed his PhD in 1974 from Lomonosov Moscow State University and his Doctor of Science in 1988 from Moscow University. He is the chief of the Department of Functional Biochemistry of Biopolymers and the chief of the Laboratory of Mitochondrial Structure and Functions in A.N.Belozersky Institute at Moscow State University. He has published more than 150 papers in high rank journals and has been serving as an editorial board member of Heart, Lung and Cirulation. He is a member of European Academy (Academia Europea).

Polymers, Nephrology

Dr. Roger De Filippo completed his MD at the Keck School of Medicine, University of Southern California, in 1993. He completed a pediatric urology fellowship in 2003 at Boston Children’s Hospital, Harvard Medical School and did two years of tissue engineering research during his fellowship training. He is Chief of Pediatric Urology at Children’s Hospital Los Angeles and Co-Director of the GOFARR Laboratory for Organ Regenerative Research and Cell Therapeutics. He has published closed to 50 manuscripts in reputed journals and presently serves on the editorial board of the journal Stem Cells Translational Medicine.

Translational Medicine, Nephrology

Dr. Borchers received his PhD from the University of Konstanz, Germany. After his post-doctoral training and staff scientist positions at NIEHS/NIH (NC, USA), he became the director of the University of North Carolina (UNC)-Duke Proteomics Facility and held a faculty position at the UNC Medical School (2001-2006). Since 2006, Dr. Borchers has been at the University of Victoria (UVic), Canada, where he currently holds the positions of Professor in the Dept. of Biochemistry & Microbiology, the Don and Eleanor Rix British Columbia (BC) Leadership Chair in Biomedical & Environmental Proteomics, and Director of the UVic-Genome BC Proteomics Centre. Dr. Borchers is also a Professor in the Dept. of Oncology at McGill University in Montreal, Canada, where he holds the Segal Chair in Molecular Oncology. Dr. Borchers' research is centered around the improvement, development, and application of proteomics and metabolomics technologies, with a major focus on quantitative techniques for clinical diagnostics; a second focus of his research is on the application of protein chemistry and MS to problems in structural proteomics.

protein chemistry,structural proteomics.

Tadashi Yamamoto has received his PhD in 1981 at the age of 31 years from Niigata University School of Medicine and postdoctoral studies in the Scripps Research Institute, CA, USA. He is the director of the Biofluid Biomarker Center, Niigata University. He has been chairing the Human Kidney and Urine Proteome Project of Human Proteome Organization (HUPO) and published more than 25 papers in reputed proteomics journals.

Kidney, Urine Proteome